SCHEMBL3936845

SCHEMBL3936845

O=C(OCc1ccccc1)O[C@@H]1CCC[C@H](O)C1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A3 Q01959 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
CYP2C19 P33261 2/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
ENPP2 Q13822 1/20 0.40
GAA P10253 1/20 0.40
FKBP1A P62942 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3936284 1.00 ALDH1A1 (0.45) ALDH1A1TSHRSMN1; SMN2NPC1RAB9A
SCHEMBL2900931 0.84 ALDH1A1 (0.50) ALDH1A1TSHRSMN1; SMN2NPC1RAB9A
SCHEMBL8316188 0.80 CHRNB2 (0.46) ALDH1A1TSHRKMT2A
SCHEMBL4175726 0.79 CTSL (0.44) ALDH1A1
SCHEMBL719173 0.79 CTSL (0.44) ALDH1A1
SCHEMBL24242210 0.79 CTSL (0.44) ALDH1A1
SCHEMBL5711147 0.79 CTSL (0.44) ALDH1A1
SCHEMBL5425580 0.77 TSHR (0.51) ALDH1A1TSHRSMN1; SMN2NPC1RAB9A
SCHEMBL5425578 0.77 TSHR (0.51) ALDH1A1TSHRSMN1; SMN2NPC1RAB9A
SCHEMBL2406746 0.77 TSHR (0.51) ALDH1A1TSHRSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1805316-B1 PROCESS FOR THE PREPARATION OF THE ENANTIOMERIC FORMS OF CIS-3-HYDROXYCYCLOHEXANE CARBOXYLIC ACID DERIVATIVES EMPLOYING HYDROLASES SANOFI AVENTIS DEUTSCHLAND (DE) 2009-04-15 EP disclosed
EP-1805316-A2 METHOD FOR PRODUCING THE ENANTIOMER FORMS OF CIS-CONFIGURED 3-HYDROXYCYCLOHEXANE CARBOXYLIC ACID DERIVATIVES USING HYDROLASES Sanofi-Aventis Deutschland GmbH (DE) 2007-07-11 EP disclosed
WO-2006015716-A2 METHOD FOR PRODUCING THE ENANTIOMER FORMS OF CIS-CONFIGURED 3-HYDROXYCYCLOHEXANE CARBOXYLIC ACID DERIVATIVES USING HYDROLASES SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-02-16 WO disclosed